Perspectives HCV

Q: お住まいの国では利用できないPerspectives HCVをダウンロードしたい時にはどうすればいい？

<a href="https://apkpure.com/howto/how-to-download-an-iphone-app-if-it-is-not-available-in-your-country">ここ</a>をクリック！地理的に制限されているアプリのダウンロード方法をご参考ください。

Q: Perspectives HCVを実行するための最小システム要件は何？

次のリストをチェックして、Perspectives HCVの最低システム要件をご確認ください。<br/><ul><li>iPhone-</li><li>iPad-</li></ul>

Free

1.1for iPhone, iPad

Comunica cc

Developer

2016年05月07日

Update Date

Entertainment

Category

APKPure

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

Perspectives HCV スクリーンショット

iPad

iPhone

About Perspectives HCV

Perspectives HCV is a mobile application designed to complete the artworks of the project 'Perspectives - Art, liver diseases and me'. The app delves into the relationship between art and diseases and brings the project the added value of technology as a medium for artistic expression. Thus, the applications offer a new outlook on some works of art, in other cases they reveal the process of creation through interviews, audio pieces and 2D and 3D animations which complete the project with a different rewarding reading.

'Perspectives - Art, Liver Diseases and Me' initiative of better understanding of HCV burden was initiated by AbbVie, coordinated by the Valencia Polytechnic University and donated to EASL.